Fulcrum Therapeutics (FULC) Non-Current Assets (2019 - 2025)
Historic Non-Current Assets for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $9.0 million.
- Fulcrum Therapeutics' Non-Current Assets fell 2191.16% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year decrease of 2925.57%. This contributed to the annual value of $10.8 million for FY2024, which is 3033.24% down from last year.
- According to the latest figures from Q3 2025, Fulcrum Therapeutics' Non-Current Assets is $9.0 million, which was down 2191.16% from $9.5 million recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Non-Current Assets peaked at $21.0 million during Q2 2022, and registered a low of $9.0 million during Q3 2025.
- Its 5-year average for Non-Current Assets is $13.9 million, with a median of $14.0 million in 2024.
- In the last 5 years, Fulcrum Therapeutics' Non-Current Assets soared by 12401.79% in 2022 and then plummeted by 3224.77% in 2025.
- Fulcrum Therapeutics' Non-Current Assets (Quarter) stood at $9.0 million in 2021, then skyrocketed by 112.91% to $19.2 million in 2022, then decreased by 19.15% to $15.5 million in 2023, then tumbled by 30.33% to $10.8 million in 2024, then fell by 16.67% to $9.0 million in 2025.
- Its Non-Current Assets was $9.0 million in Q3 2025, compared to $9.5 million in Q2 2025 and $10.1 million in Q1 2025.